The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such therapies are aiding in improving the lean body mass (LBM) of patients. This information is given by Fortune Business Insights™ in a recently published report, titled, “Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further states that this market size was USD 2.02 billion in 2019 and is projected to reach USD 2.93 billion by 2027, thereby exhibiting a CAGR of 4.8% during the forecast period.
To Understand Cancer Cachexia Market Key Trends, Download Sample Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cancer-cachexia-market-103262
The emergence of the COVID-19 pandemic has brought the entire world to a standstill. The governments of several countries have implemented lockdown measures to prevent the spread of this deadly infection. Such initiatives have caused disruptions in the production and supply chain. But, with time and perseverance, we will be able to battle this severe phase and come back to normalcy. Our authentic reports would help you to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.
Drivers & Restraints-
Rising Incidence of Cancer Cachexia to Skyrocket Demand
The rising prevalence of cachexia, as well as cancer is further creating a huge patient pool requiring treatment for the same. The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD), a non-profit organization, mentioned in a report that in the developing nations, approximately 0.5-1.0% of the total population suffer from cancer cachexia. Besides, the World Health Organization (WHO) declared that around 18.1 million new cases of cancer were reported in 2018 globally. These researches prove that the demand for cancer cachexia therapeutics is set to surge in the near future. However, the strict government rules and regulations regarding the clinical trials of new candidates may hamper the cancer cachexia market growth in the coming years.
Quick Buy - Cancer Cachexia Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/103262
Competitive Landscape-
Key Players to Invest Hefty Amounts in R&D for Creating Novel Drugs
The global market is presently underpenetrated with the presence of very few companies worldwide. This is mainly occurring because of the lack of approved therapeutics for the treatment of cancer cachexia. However, some of the companies are investing in R&D activities to come up with new drug candidates. Below are two of the latest industry developments:
- July 2019: Mylan N.V., and Pfizer Inc., entered into a definitive agreement to form a new company named Viatris. It would help both companies to fulfill the growing demand for innovative treatment options from the patients, as well as broaden their access to medicines.
- November 2019: Bristol-Myers Squibb Company successfully acquired Celgene Corporation to create a strong biopharma company. As per the officials of Bristol, its expertise in the fields of cardiovascular disease, hematology, immunology, and oncology would aid in transforming the lives of the patients through technological advancements.
Fortune Business Insights™ presents a list of all the providers of cancer cachexia therapeutics operating in the global market. They are as follows:
- Bristol-Myers Squibb Company, New York, U.S.
- ANI Pharmaceuticals, Inc., Baudette, U.S.
- Merck & Co., Inc., Kenilworth, U.S.
- Hikma Pharmaceuticals PLC, London, U.K.
- Mylan N.V., Pennsylvania, U.S.
- AbbVie, Inc., North Chicago, U.S.
- Pfizer Inc., New York, U.S.
- Teva Pharmaceutical Industries Ltd., Petach-Tikva, Israel
This Report Answers the Following Questions:
- What are the market drivers, dynamics, and hindrances?
- How will the COVID-19 pandemic affect the market in the coming years?
- Which strategies are presently adopted by the companies to intensify competition?
- What are the estimated, current, and historical sizes of the market?
- Which region is set to dominate the market in terms of revenue?
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cancer-cachexia-market-103262
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the cancer cachexia market include Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corp, Eli Lilly and Co., GTx Inc., Helsinn Group, Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio Pharmaceuticals, Inc., Astellas Pharma Inc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Cancer Cachexia Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/cancer-cachexia-market/download-sampleMarket DynamicsThe global cancer cachexia market is estimated to witness promising growth during the forecast period.
Soaring cases of cancer worldwide and escalating post-operative complications drive the global cancer cachexia market.
New therapies are being proposed to treat the syndrome effectively.
This is foreseen to bring new attributes to the market.
